Celavrin supports studies across a wide range of therapeutic categories. Below are the major areas in which clinical trials are actively conducted or currently enrolling through our network.
Studies focusing on hypertension, coronary artery disease, heart failure, arrhythmia, and related conditions affecting the heart and circulatory system.
Research targeting Type 2 diabetes, obesity, insulin resistance, lipid disorders, and other metabolic conditions affecting energy regulation and organ function.
Investigations into Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and other conditions affecting cognitive and neurological function.
Studies evaluating new approaches to asthma, COPD, interstitial lung disease, and other conditions affecting breathing and pulmonary capacity.
Trials evaluating novel therapies, immunotherapies, and combination approaches for a range of cancer types, from early-stage to advanced disease.
Research into osteoarthritis, rheumatoid arthritis, osteoporosis, and other conditions affecting mobility, joint function, and musculoskeletal health.
Studies on Crohn's disease, irritable bowel syndrome, ulcerative colitis, GERD, and other digestive and GI tract conditions.
Research into vaccines, antiviral treatments, and therapeutic interventions for bacterial, viral, and fungal infections.
Clinical studies targeting psoriasis, eczema, acne, rosacea, and other conditions affecting skin health and appearance.
Trials examining treatments for depression, anxiety disorders, PTSD, and other behavioral health conditions with significant unmet medical need.
Active enrollment varies by study and location. Not every category listed above is enrolling in every region at all times. Contact our team to learn which studies are currently open and whether you may meet the eligibility criteria for any of them.
Check Current Availability